Clinical Data

Pfizer, BioNTech Halt Large US COVID-19 Vaccine Trial Over Slow Enrollment

BioSpace

COVID-19 partners Pfizer and BioNTech have been unable to recruit healthy adults aged 50 to 64 fast enough to deliver relevant post-marketing data.

Clinical Data Infectious Disease Read full story

pharminent April 2, 2026 (Last updated: April 2, 2026)

BioSpace

COVID-19 partners Pfizer and BioNTech have been unable to recruit healthy adults aged 50 to 64 fast enough to deliver relevant post-marketing data.

Clinical Data Infectious Disease Read full story